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Abstract
Variation in gene expression has been observed in natural populations and associated with complex traits or phenotypes
such as disease susceptibility and drug response. Gene expression itself is controlled by various genetic and non-genetic
factors. The binding of a class of small RNA molecules, microRNAs (miRNAs), to mRNA transcript targets has recently been
demonstrated to be an important mechanism of gene regulation. Because individual miRNAs may regulate the expression
of multiple gene targets, a comprehensive and reliable catalogue of miRNA-regulated targets is critical to understanding
gene regulatory networks. Though experimental approaches have been used to identify many miRNA targets, due to cost
and efficiency, current miRNA target identification still relies largely on computational algorithms that aim to take
advantage of different biochemical/thermodynamic properties of the sequences of miRNAs and their gene targets. A novel
approach, ExprTarget, therefore, is proposed here to integrate some of the most frequently invoked methods (miRanda,
PicTar, TargetScan) as well as the genome-wide HapMap miRNA and mRNA expression datasets generated in our laboratory.
To our knowledge, this dataset constitutes the first miRNA expression profiling in the HapMap lymphoblastoid cell lines. We
conducted diagnostic tests of the existing computational solutions using the experimentally supported targets in TarBase as
gold standard. To gain insight into the biases that arise from such an analysis, we investigated the effect of the choice of
gold standard on the evaluation of the various computational tools. We analyzed the performance of ExprTarget using both
ROC curve analysis and cross-validation. We show that ExprTarget greatly improves miRNA target prediction relative to the
individual prediction algorithms in terms of sensitivity and specificity. We also developed an online database, ExprTargetDB,
of human miRNA targets predicted by our approach that integrates gene expression profiling into a broader framework
involving important features of miRNA target site predictions.
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Introduction
Gene expression is a fundamental phenotype that affects
complex cellular, physiological and clinical phenotypes including
disease risk as well as individual response to therapeutic treatment.
For example, gene expression alterations have been implicated in
the etiologies of common diseases such as cancers [1–3],
cardiovascular diseases [4], and psychiatric disorders [5]. Previous
studies using the International HapMap Project [6,7] lympho-
blastoid cell lines (LCLs) derived from individuals of European
(CEU: Caucasians from Utah, USA), African (YRI: Yoruba people
from Ibadan, Nigeria) and Asian (CHB: Han Chinese from
Beijing, China; JPT: Japanese from Tokyo, Japan) ancestry have
shown that common genetic variants including single nucleotide
polymorphisms (SNPs) and copy number variants (CNVs) account
for a substantial fraction of variation in gene expression within a
population and between populations [8–14]. Furthermore,
pharmacogenomic studies based on these HapMap cell lines
[6,7] strongly suggest that response to therapeutic treatment is
likely to be a complex phenotype affected by genetic factors that
alter gene regulation, especially in the form of eQTLs (expression
quantitative trait loci) [15–17].
In addition to eQTLs, more recently, microRNAs (miRNAs)
(,700 known in humans to date), a family of small (21–23
nucleotides), single-stranded, non-coding RNAs, have been shown
to be an important class of gene regulators that generally down-
regulate gene expression through sequence-specific binding to the
39 untranslated regions (UTRs) of target mRNAs [18]. In humans,
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protein-coding genes [19]. Global microRNAome profiling has
demonstrated significant changes in the expression of multiple
miRNAs in a growing list of human diseases, including
neurodegenerative diseases [20], heart diseases [21] and cancer
[22]. Because an individual miRNA may regulate multiple
mRNAs, a comprehensive and reliable catalogue of miRNA gene
targets should enhance our understanding of the complexity of
gene regulatory networks in a cell, as well as facilitate the shifting
of focus from miRNA gene identification to functional character-
ization. Due to the lack of high throughput experimental
technique for identifying the targets of miRNAs, only a small
proportion of the targets of the potentially more than 1000 human
miRNAs – such as those in TarBase [23,24] (a manually curated
database of experimentally supported miRNA targets) – have been
confirmed experimentally. Therefore, several computational and
bioinformatic approaches have been developed for large-scale
prediction of miRNA targets including miRanda [25,26] (based on
sequence complementarity, free energy of the RNA-RNA duplex,
extent of conservation), TargetScan [27–29] (based on seed
complementarity, thermodynamic free energy of binding, conser-
vation over different species), and PicTar [30] (based on seed
complementarity, thermodynamics and a combinatorial prediction
for common targets in sets of coexpressed miRNAs). The various
computational prediction algorithms have been found to suffer
from significant false positive and false negative rates. For
example, the miRanda algorithm [25,26] was estimated to have
a high false-positive rate at 24–39% in an early study [31]. A high
false-negative rate is also expected for the current miRNA target
prediction programs, largely due to their requirements for
evolutionary conservation, while many of the experimentally-
supported targets (e.g., those from TarBase [23,24]) may not be
conserved in other species [32]. Though using combinations of
two or more of these computational approaches may improve the
sensitivity or specificity of the prediction, the degree of overlap of
their predictions is poor [32]. To date, a few algorithms have been
developed to leverage existing approaches involving relevant
miRNA binding site considerations such as thermodynamics,
sequence complementarity, conservation, and gene expression
profiles [32]; however none of these algorithms provide a genome-
wide map of predictions that utilizes post-transcriptional regula-
tion within a broad framework of relevant target site prediction
features as well as utilizes the experimentally validated binding
sites as training set.
Though experimental testing is critically important for validat-
ing any putative miRNA targets, we propose here a novel
bioinformatic approach, ExprTarget (Fig. 1), to predicting human
miRNA targets by integrating select computational algorithms and
our recently-generated miRNA expression data and previously
published mRNA data [33] on 58 unrelated HapMap CEU LCLs
[6,7]. We demonstrate that a significant improvement of
performance in terms of sensitivity and specificity can be achieved
by integrating both the computational algorithms as well as the
experimental miRNA expression data. Furthermore, the study we
report here of miRNA-mRNA relationships in the HapMap
samples [6,7] extends, in the direction of miRNA-mediated gene
regulation, earlier studies on these same samples that have
successfully been used as models for studies of complex traits
[34] and for pharmacogenomic studies [15–17]. We developed an
online resource, ExprTargetDB (http://www.scandb.org/apps/
microrna/) to: 1) enable user-friendly queries of a comprehensive
catalogue of miRNA targets using this integrative approach; 2)
provide a reference dataset of miRNA-mRNA relationships on the
HapMap samples and; 3) advance our understanding of gene
regulatory networks and of the contribution of miRNAs to
complex traits.
Results
Pair-wise comparisons between prediction algorithms
Pair-wise comparisons show that the miRNA targets predicted
by different algorithms are generally not correlated (Fig. 2A, 2B,
2C) in the sense that good candidates for one algorithm do not
tend to be good candidates for the other algorithms. PicTar [30]
scores, TargetScan [27–29] scores and miRanda [25,26] scores
are not correlated for the same miRNA targets predicted by these
algorithms. We compared the distribution of experimentally-
validated targets (from TarBase [23,24]) using the targets’
miRanda [25,26] scores (Fig. 2D), PicTar [30] scores (Fig. 2E)
and TargetScan [27–29] scores (Fig. 2F) with the corresponding
overall distribution of scores. This analysis enables us to compare,
for each score bin defined by an algorithm, the proportion of
target site predictions and the proportion of experimentally
validated predictions falling within the bin; particularly, it shows
the proportion of experimentally supported targets that overlap
with the highest scoring bins.
Performance of individual prediction algorithms
Individual prediction algorithms were evaluated for perfor-
mance (see Materials and Methods) using either TarBase [23,24]
alone or TarBase [23,24] combined with the expression-
corroborated miRNA targets (TarBase+LCL) as gold standard.
The receiver operating characteristic (ROC) curves, which plot the
true positive rate (sensitivity) and false positive rate (1-specificity),
for the individual algorithms are shown in Fig. 3. Each point on
the ROC curve is a specificity/sensitivity pair corresponding to a
score threshold. A comparison of the diagnostic performance of
the three prediction algorithms using only TarBase [23,24] as gold
standard is shown in Fig. 3 (Fig. 3A, 3B, 3C). The same analysis
was repeated using (TarBase+LCL) as gold standard to gauge the
Figure 1. ExprTarget integrates various methods and datasets.
Individual computational methods (miRanda, PicTar, TargetScan) were
evaluated using both TarBase and (TarBase + LCL) as gold standards.
ExprTarget integrates individual computational methods (miRanda,
PicTar, TargetScan) and the LCL expression data. ExprTarget was
evaluated using TarBase as gold standard. ExprTargetDB was developed
to house the predictions by ExprTarget. LCL refers to the miRNA and
mRNA expression data generated on a panel of lymphoblastoid cell
lines from the HapMap.
doi:10.1371/journal.pone.0013534.g001
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PLoS ONE | www.plosone.org 2 October 2010 | Volume 5 | Issue 10 | e13534effect of the choice of gold standard; the results for the three
prediction approaches are shown in Figure S1.
Integrating different algorithms and miRNA expression in
miRNA target prediction
By incorporating the computational approaches included in this
study (miRanda [25,26], PicTar [30] and TargetScan [27–29]) as
well as the expression-based prediction model into an integrative
model ExprTarget based on sigmoidal modeling (see Materials and
Methods), we observed that the performance in terms of sensitivity
and specificity is greatly improved using TarBase [23,24] as gold
standard (Fig. 4). A similar ROC-based performance evaluation
shows that ExprTarget is a much better classifier in discriminating
the experimentally verified targets from the non-experimentally
supported ones than the random guessing procedure indicated by
the line of no-discrimination (Fig. 4) or, indeed, any of the existing
computational solutions (Fig. 3) evaluated in this study. Reduced
models (e.g., the combination of two individual methods as well as
the expression-based approach) lead to decreased predictive
performance, as measured by the area under the ROC curve.
Restricting the gold standard to the subset of TarBase [23,24] that
excludes the high-throughput assays, we observed that the
improvement in predictive performance for ExprTarget relative
to the individual methods continues to hold robustly (Figure S2).
From each computational algorithm incorporated by ExprTarget, a
parameter that quantifies the confidence of each binding site is used
so that the final model is target-site based. The use of a score from
the expression data that is gene-based rather than target-site based
(e.g., when the score from the expression data is defined as the
minimum ofallp valuesforthegene)demonstratestherobustness of
our primary finding, namely, incorporating these algorithms
through sigmoidal modeling improves predictive performance
(Figure S3). To evaluate whether the fitted model can be
generalized to as-yet-unseen data (given that ExprTarget uses the
experimentally validated targets as training set), we proceeded to do
cross-validation (see Materials and Methods) on ExprTarget. Cross-
validation enabled us to evaluate how well our predictive model,
which was defined by the use of training data, would perform on
future data. Using 10-fold cross validation, ExprTarget resulted in a
mean prediction error of 0.000277.
Figure 2. Prediction results from existing computational approaches are not correlated. Prediction scores (TargetScan, PicTar, and
miRanda) for the same miRNA targets are plotted to show pair-wise comparisons (A, B, C). The distributions of scores for targets from the TarBase
(experimentally-validated) are shown with the scores for the full set of targets from individual prediction algorithms (D, E, F). (A) miRanda (x-axis)
scores are plotted against PicTar scores (y-axis); (B) miRanda (x-axis) scores are plotted against TargetScan scores (y-axis); (C) PicTar scores (x-axis) are
plotted against TargetScan scores (y-axis); (D) Histogram of experimentally-validated targets with the distribution of miRanda scores (left y-axis is for
the miRanda p values; right y-axis is for the TarBase targets); (E) Histogram of experimentally-validated targets with the distribution of PicTar scores
(left y-axis is for the PicTar scores; right y-axis is for the TarBase targets); and (F) Histogram of experimentally-validated targets with the distribution of
TargetScan scores (left y-axis is for the TargetScan scores; right y-axis is for the TarBase targets).
doi:10.1371/journal.pone.0013534.g002
MicroRNA Gene Targets
PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13534ExprTargetDB, a database for human miRNA targets
We developed a web-based database, ExprTargetDB (http://
www.scandb.org/apps/microrna/), to provide user-friendly que-
ries of our miRNA-mRNA association data in the context of other
computationally-predicted miRNA targets including miRBase
[25,26], TargetScan [27–29] and PicTar [30] as well as the
experimentally-supported miRNA targets [23,24]. The miRNA
expression profiling is, to our knowledge, the first such reported
dataset on the HapMap samples. Though the initial dataset was
generated from the samples of European descent only, ExprTar-
getDB will hold the results assayed from other HapMap
populations. Since previous studies on the HapMap samples have
Figure 3. Individual performance of foundational prediction algorithms. The three prediction algorithms were evaluated using ROC curves,
which plot the true positive rate (sensitivity) and the false positive rate (1-specificity) at various score thresholds. TarBase was used as gold standard.
The line of no-discrimination was drawn from the left bottom to the top right corners. (A) miRanda vs. TarBase; (B) PicTar vs. TarBase; and (C)
TargetScan vs. TarBase.
doi:10.1371/journal.pone.0013534.g003
Figure 4. Performance of ExprTarget, an integrative prediction algorithm. ExprTarget was assessed by plotting the ROC curve, which shows
the true positive rate (sensitivity) and the false positive rate (1-specificity) at various thresholds. The database of manually-curated experimentally
verified targets, TarBase, was used as gold standard. The line of no-discrimination was drawn from the left bottom to the top right corners.
doi:10.1371/journal.pone.0013534.g004
MicroRNA Gene Targets
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[15–17] are affected by genetic variants that alter gene regulation,
this dataset on miRNA-mediated gene regulation should be a
tremendous resource to the scientific community. ExprTargetDB
supports downloading of the complete list of expression-corrob-
orated miRNA targets. In addition, ExprTargetDB can be queried
by either miRNA or gene target, in single or batch mode. A query
of miRNA should utilize the nomenclature of the miRBase [25,26]
(e.g., ‘‘hsa-miR-138’’), while a query for gene target should use the
official gene symbols (e.g., ‘‘PAPD5’’). A successful search outputs a
table of miRNA targets (miRNA-centric) or miRNAs (gene target-
centric). A link to our SCAN database (SNP and CNV
Annotation, http://www.scandb.org/) [35] is also provided for
more information on eQTLs of the gene targets to supplement the
information on miRNA-mediated gene regulation. A search
example is discussed in the online tutorial.
Discussion
The identification of the transcript targets regulated by miRNAs
promises to greatly enhance our understanding of gene regulation
and to provide important insights into the genetic/epigenetic basis
of various human diseases such as those that have been found to be
associated with altered or abnormal miRNA expression [20–22].
As a result of the multiplicity of computational algorithms that
have been developed, two distinct problems arise: (1) the problem
of inter-method reliability, and (2) the problem of integrating the
results obtained from the various methods into a single optimal
score. The present study conducted a comparative analysis of the
most frequently used target prediction algorithms and developed
an integrative approach, with certain analytically attractive
properties, that improves the predictive performance in relation
to the foundational prediction methods.
The problem of inter-method reliability is concerned with the
degree of agreement between the various computational methods
and with the predictive performance of each algorithm. Many
available computational prediction methods take advantage of the
biochemical or thermodynamic properties of the binding between
miRNAs and their cognate mRNA transcripts. For the three
frequently used algorithms we tested (i.e., miRanda [25,26],
PicTar [30], TargetScan [27–29]), pairwise comparisons reveal
that their prediction results are generally not correlated. This
unanticipated lack of correlation between these prediction
algorithms presumably reflects the differing emphasis on bio-
chemical/thermodynamic factors as well as the extent of the use of
evolutionary conservation. Surprisingly, we found very different
distributional patterns for the existing prediction approaches when
comparing the experimentally-validated miRNA targets (from
TarBase [23,24]) predicted by an algorithm with the full set of
targets for the same algorithm. For example, Fig. 2D shows that
the distribution of miRanda [25,26] scores for predicted targets is
similar to the distribution of miRanda [25,26] scores for only the
experimentally supported targets; each is bell-shaped and peaks in
the same score bin. In contrast, the distributions of the scores from
the other two methods show quite distinct patterns.
An ROC analysis using TarBase [23,24] on each of the existing
computational methods would seem to suggest that TargetScan
[27–29] may yield slightly better performance than the other
computational methods, based on the area under the ROC curve
(AUC). However, caution must be exercised in the interpretation
of these results. We sought to evaluate the effect of the choice of
gold standard on the performance evaluation. A comparative
ROC analysis for the three methods, using either TarBase [23,24]
or (TarBase+LCL), shows the dependence of the performance
evaluation on the use of a different gold standard. TarBase [23,24]
is a manually-curated database with results that assume particular
prediction approaches and that were derived during the
experimental verification of a prediction algorithm; on the other
hand, it has also been shown that a substantial proportion of
TarBase predictions are non-conserved target sites and would not
have been predicted by computational approaches that assume
evolutionary conservation [32]. Due to these biases, it is
informative to assess the performance of the individual computa-
tional approaches using another benchmark. The miRNA-mRNA
associations generated from our HapMap LCL [6,7] data are
genome-wide, facilitate a comparative analysis, and may serve as a
reference dataset on the regulatory effects of miRNAs. However,
this gold standard could reflect the possible biases from the high-
throughput expression microarrays.
The problem of integrating existing computational approaches
is concerned with identifying a parsimonious model, which utilizes
the accumulated knowledge base of experimentally supported
miRNA target sites in defining the training algorithm. The
parsimonious model is selected from a potential hierarchy of
models derived from various combinations of existing algorithms.
ExprTarget is inspired by a multivariate logistic regression model
for a binary outcome and predictor variables from existing
computational solutions. ExprTarget has certain attractive features
besides the relevant criterion of parsimony. In relation to existing
computational methods, ExprTarget shows a greater predictive
power to discriminate the experimentally verified targets based on
ROC curve analysis. To gauge the accuracy, we conducted K-fold
cross-validation (K=10) on our proposed algorithm, resulting in a
mean prediction error of 0.000277. There are, of course, other
ways of combining individual computational approaches such as
taking various unions or various intersections of the corresponding
result sets. However, while unions of computational approaches
may achieve a higher level of sensitivity than the individual
approaches, this gain comes at the cost of a reduction in specificity.
In the same vein, while intersections of computational approaches
may achieve a higher level of specificity, they also generally
achieve a much reduced sensitivity [32]. Alternatively, non-linear
statistical models may provide an excellent fit; however, the
parameters in these models are often difficult to interpret. The
application of a complex model with many degrees of freedom to
produce a satisfactory fit may come at the cost of failure to
replicate in as-yet-unseen data. The model we propose in
ExprTarget enables us to evaluate the relative importance of the
predictors in miRNA target site prediction.
We acknowledge that miRNA-mediated regulation of gene
expression may be tissue-specific and population-specific. Our
miRNA expression data on LCLs represent one tissue type in one
population (the CEU samples); therefore, it is likely that we might
miss some information on miRNAs not expressed in these samples
or differentially expressed between human populations. Neverthe-
less, the approach we propose here is completely extensible. With
the availability of more data sets on other tissues (e.g., liver) and
the development of new methods that may utilize novel
characteristics of the miRNA-mRNA relationships, ExprTarget
is amenable to refinement to guide the prediction of miRNA
targets.
Finally, the prediction results of our integrative approach are
provided through an online searchable database, ExprTargetDB,
which can also be used to compare the prediction results (i.e.,
p values, scores) from the various computational solutions we
tested in this study (i.e, miRanda [25,26], PicTar [30], TargetScan
[27–29], TarBase [23,24], and our LCL data). In particular, the
expression dataset in ExprTargetDB constitutes the first reported
MicroRNA Gene Targets
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samples [6,7] that have been so important in transcriptome-based
studies of complex traits [34] and pharmacologic phenotypes [17].
Given the role of miRNAs on the regulation of expression, we also
provide additional relevant information (e.g., eQTL annotation
through the SCAN database [35]) in ExprTargetDB to inform
studies of the complex networks of gene expression. ExprTar-
getDB has been designed to seamlessly integrate into existing
genomic and pharmacogenomic resources (e.g., PharmGKB [36]).
Materials and Methods
MiRNA profiling of unrelated HapMap LCLs
MiRNA expression was measured in unrelated HapMap LCLs
[6,7] including 58 CEU (Caucasians from Utah, USA) samples
using the Exiqon miRCURY
TM LNA Array v10.0 (,700 human
miRNAs, updated to miRBase 11.0 annotation [25,26]) (Exiqon,
Inc., Denmark). The HapMap cell lines [6,7] were purchased from
Coriell Institute for Medical Research (Camden, NJ). The details
for cell line culture were described in a previous publication [10].
Total RNA was extracted using miRNeasy Qiagen Kit (Qiagen,
Inc., Valencia, CA) according to manufacturer’s protocol. Array
hybridization was performed by Exiqon. The quantified signals
were background corrected using normexp with offset value 10
based on a convolution model [37] and normalized using the
global Lowess regression algorithm. In total, 225 miRNAs were
found to be expressed in these samples (unpublished data).
Expression-supported human miRNA targets
Associations between the 225 expressed miRNAs and potential
gene targets were evaluated using the miRNA profiling data and
our previously-generated Affymetrix Human Exon 1.0ST array
data on the same cell lines (,10,000 mRNA transcripts with
reliable expression) (NCBI Gene Expression Omnibus Accession:
GSE9703) [33]. Association analyses in the CEU samples
were carried out using the lm function of the R Statistical Package
[38].
Computationally-predicted miRNA targets
1. The miRBase Targets Release Version v5 (http://www.ebi.ac.
uk/enright-srv/microcosm/htdocs/targets/v5/) (i.e., micro-
Cosm) provides computationally predicted targets for miRNAs
using the miRanda algorithm [25,26], which uses dynamic
programming to search for maximal local complementarity
alignments corresponding to a double-stranded anti-parallel
duplex. miRanda [25,26] also takes into account the extent of
conservation of the miRNA targets across related genomes.
The miRBase Targets Release Version v5 is comprised of gene
target predictions for 711 human miRNAs.
2. TargetScan (http://www.targetscan.org/) (TargetScanHuman
Release 5.1, April, 2009) [27–29] predicts miRNA gene targets
by searching for the presence of conserved sites that match the
seed region of each miRNA. Predictions are ranked using site
number, site type, and site context, which include factors that
influence target-site accessibility.
3. PicTar [30] (http://pictar.mdc-berlin.de/) takes sets of coex-
pressed miRNAs and searches for combinations of miRNA
binding sites in each 39UTR. Like TargetScanS [27–29],
PicTar also requires target conservation across several species
[30]. PicTar has target prediction information for human
miRNAs based on conservation in mammals (human, chim-
panzee, mouse, rat, dog) [30].
Experimentally-supported human miRNA targets
TarBase [23,24] (http://diana.cslab.ece.ntua.gr/tarbase/),
which houses a manually curated collection of experimentally
tested miRNA targets in a variety of species including human,
mouse and several other model organisms. Each target site is
described by the miRNA that binds it, the gene in which it occurs,
the nature of the experiments that were conducted to test it, the
sufficiency of the site to induce translational repression and/or
cleavage, and the paper from which all these data were extracted.
The current TarBase [23,24] v.5c (June, 2008) covers 1122 distinct
miRNA-gene pairs for 143 human miRNAs.
Comparing computationally-predicted and
experimentally-supported miRNA targets
1. Pair-wise comparisons of miRanda scores [25,26], PicTar
scores [30] and TargetScan scores [27–29] were performed to
evaluate the correlations between the computational algo-
rithms. Predicted miRNA targets overlapping between every
pair were included in this analysis: 21590 between miRanda
[25,26] and TargetScan [27–29], 2465 between miRanda
[25,26] and PicTar [30], and 8707 between TargetScan [27–
29] and PicTar [30].
2. The distribution of experimentally-supported miRNA targets
from TarBase [23,24] for each algorithm was compared with
the distribution of the full set of miRNA targets predicted by
the same algorithm. The overlap of miRNA targets between
TarBase [23,24] and each computational algorithm were
included in each comparison. For example, the distribution of
miRanda-predicted miRNA targets [25,26] was compared with
the distribution of targets among them supported by TarBase
[23,24].
ExprTarget: An integrative approach to miRNA target
prediction
We constructed a computational prediction model that
integrates select miRNA computational algorithms using the
experimentally validated targets as training data. Following a
multivariate logistic regression model, let the xj,i be the prediction
score of algorithm j on the i-th miRNA target site prediction:
log it(pi)~ln(
pi
1{pi
)~b0zb1x1,iz:::zbkxk,i
where pi defines the score for ExprTarget that may be derived
from a sigmoidal transformation of a weighted sum of the scores
from select computational algorithms or target site features:
pi~sigmoid(
X
bkxk,i)
sigmoid(s)~
1
1zexp({s)
Pictar [30], TargetScan [27–29], miRanda [25,26], and our
HapMap-based expression microarray dataset were selected as
providing the xj,i, although the approach we describe here may
extend to a larger list provided certain assumptions are met.
Estimated from the data, each beta bk describes the size of the
contribution from a target site feature (encapsulated by the
prediction algorithm k). The model, as stated, characterizes the
relationship between the various predictors and a binary variable,
MicroRNA Gene Targets
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experimentally supported or not. A high absolute magnitude for
the parameter bk implies that the incorporation of the respective
target prediction feature increases the probability of experimental
support. The PicTar [30] score, which has a maximum=1000,
has been normalized to lie between 0 and 1 by dividing by this
maximum value. The score for the expression-corroborated
miRNA targets is set to the p value for the general linear model
between miRNA and mRNA normalized (log2-transformed)
expression intensities, provided the estimated coefficient is
negative; otherwise, the expression-based score is set to 1. For
the miRanda [25,26] contribution, we used the algorithm’s Score,
which is based on complementary base pairing as well as the
presence of mismatches, gap-opening, and gap-extension. For
TargetScan [27–29], we utilized the probability of preferentially
conserved targeting (PCT), a Bayesian estimate of the probability of
site conservation due to selective maintenance of miRNA
targeting. Alternatively, one could utilize the TargetScan context
score, which is meant to provide complementary information to
PCT and is derived from information orthogonal to site
conservation [27–29]; however, our analysis shows that the use
of context scores does not lead to higher predictive performance
based on AUC (see next section). The change in ExprTarget score
p with respect to the change in score xi for a given prediction
method is given by:
Lp
Lxi
~p(1{p)bi
Performance evaluation using ROC curve analysis and
cross-validation
The various prediction algorithms were assessed using the
receiver operating characteristic (ROC) curves, which plot the true
positive rate (sensitivity) and the false positive rate (1-specificity) for
a binary classifier at various score thresholds [39]. The
performance of a prediction algorithm can be evaluated using
the area under the ROC curve (AUC). The area estimate V has
the following standard error (SE):
SE(V)~(
h(1{h)z(nA{1)(Q1{h
2)z(nN{1)(Q2{h
2)
nAnN
)
1=2
where nA and nN are the number of ‘‘failures’’ and ‘‘successes’’, h is
the ‘‘true’’ area, and Q1 and Q2 are distribution specific quantities
[40]:
Q1~
h
2{h
Q2~
2h
2
1zh
Two prediction algorithms with AUC values V1 and V2 may be
compared. We can determine the standard error for the difference
in areas as follows [41]:
SE(V1{V2)~(SE2(V1)zSE2(V2){2rSE(V1)SE(V2))
1
2
where r is the estimated correlation between V1 and V2. The test
statistic for the comparison of areas is defined as follows:
Z~
V1{V2
SE(V1{V2)
*N(0,1)
Since the experimentally supported targets in TarBase may
represent biases (e.g., relative to sequence conservation), we chose
to evaluate the performance of each algorithm (miRanda [25,26],
Pictar [30] and TargetScan [27–29]) using TarBase [23,24] first as
gold standard followed by using TarBase [23,24] and expression-
corroborated predictions (TarBase + LCL) as gold standard. We
also evaluated the predictive performance of ExprTarget using as
gold standard the subset of TarBase [23,24] that includes only the
target sites validated by individual experiments rather than by
high-throughput assays.
T of u r t h e ra s s e s st h ep r e d i c t i v ep o w e ro fo u ri n t e g r a t i v e
approach, we conducted K-fold cross-validation on the training
algorithm in ExprTarget. This method partitions the entire
dataset into K subsets or folds Fi, i=1,2,…K.O n eo ft h eK
subsets is used as a validation set, Ftest where test {1,2,…,K},
and the remaining K21 subsets are combined into a training set
Ftrain to fit our weighted logistic regression model. The training
algorithm is repeated K times so that each subset is used as a
validation set once, and an average error is calculated. All
observed data are thus used in the training and the validation.
We utilized the cv.glm function for cross-validation in general-
ized linear models in the boot package available in R [38]. For
K=10, the mean error was 0.00027725 while for K=3, the
mean error was 0.00027719.
Supporting Information
Figure S1 Individual performance of foundational prediction
algorithms using (TarBase + LCL) as gold standard. The three
prediction algorithms were evaluated using ROC curve analysis,
using (TarBase + LCL) as benchmark.
Found at: doi:10.1371/journal.pone.0013534.s001 (2.30 MB TIF)
Figure S2 When the subset of TarBase that excludes the high-
throughput assays is used as gold standard, the improvement in
predictive performance for ExprTarget relative to the individual
methods continues to hold robustly.
Found at: doi:10.1371/journal.pone.0013534.s002 (1.02 MB TIF)
Figure S3 The use of a score from the expression data that is
gene-based rather than target site-based (e.g., the score is defined
as the minimum of all p values for miRNA correlations with the
gene) shows that the incorporation of the individual algorithms
improves predictive performance.
Found at: doi:10.1371/journal.pone.0013534.s003 (1.35 MB TIF)
Acknowledgments
The authors would like to thank Wasim K. Bleibel for his excellent
technical support in preparing samples for miRNA analysis and Dr.
Stephanie Huang for some helpful discussion.
Author Contributions
Conceived and designed the experiments: ERG YAL NJC MED WZ.
Performed the experiments: ERG SD. Analyzed the data: ERG HKI.
Contributed reagents/materials/analysis tools: ERG HKI SD WZ. Wrote
the paper: ERG HKI YAL MED WZ.
MicroRNA Gene Targets
PLoS ONE | www.plosone.org 7 October 2010 | Volume 5 | Issue 10 | e13534References
1. Sotiriou C, Pusztai L (2009) Gene-expression signatures in breast cancer.
N Engl J Med 360: 790–800.
2. Nannini M, Pantaleo MA, Maleddu A, Astolfi A, Formica S, et al. (2009) Gene
expression profiling in colorectal cancer using microarray technologies: results
and perspectives. Cancer Treat Rev 35: 201–209.
3. Bacher U, Kohlmann A, Haferlach T (2009) Perspectives of gene expression
profiling for diagnosis and therapy in haematological malignancies. Brief Funct
Genomic Proteomic 8: 184–193.
4. Seo D, Ginsburg GS, Goldschmidt-Clermont PJ (2006) Gene expression analysis
of cardiovascular diseases: novel insights into biology and clinical applications.
J Am Coll Cardiol 48: 227–235.
5. Xu B, Karayiorgou M, Gogos JA MicroRNAs in psychiatric and neuro-
developmental disorders. Brain Res 1338: 78–88.
6. The International HapMap Consortium (2003) The International HapMap
Project. Nature 426: 789–796.
7. The International HapMap Consortium (2005) A haplotype map of the human
genome. Nature 437: 1299–1320.
8. Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, et al. (2004)
Genetic analysis of genome-wide variation in human gene expression. Nature
430: 743–747.
9. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, et al. (2007)
Relative impact of nucleotide and copy number variation on gene expression
phenotypes. Science 315: 848–853.
10. Zhang W, Duan S, Kistner EO, Bleibel WK, Huang RS, et al. (2008) Evaluation
of genetic variation contributing to differences in gene expression between
populations. Am J Hum Genet 82: 631–640.
11. Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, et al. (2007)
Common genetic variants account for differences in gene expression among
ethnic groups. Nat Genet 39: 226–231.
12. Stranger BE, Nica AC, Forrest MS, Dimas A, Bird CP, et al. (2007) Population
genomics of human gene expression. Nat Genet 39: 1217–1224.
13. Storey JD, Madeoy J, Strout JL, Wurfel M, Ronald J, et al. (2007) Gene-
expression variation within and among human populations. Am J Hum Genet
80: 502–509.
14. Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, et al. (2005)
Genome-wide associations of gene expression variation in humans. PLoS Genet
1: e78.
15. Zhang W, Dolan ME (2009) Use of cell lines in the investigation of
pharmacogenetic loci. Curr Pharm Des 15: 3782–3795.
16. Welsh M, Mangravite L, Medina MW, Tantisira K, Zhang W, et al. (2009)
Pharmacogenomic discovery using cell-based models. Pharmacol Rev 61:
413–429.
17. Gamazon ER, Huang RS, Cox NJ, Dolan ME (2010) Chemotherapeutic drug
susceptibility associated SNPs are enriched in expression quantitative trait loci.
Proc Natl Acad Sci U S A 107: 9287–9292.
18. He L, Hannon GJ (2004) MicroRNAs: small RNAs with a big role in gene
regulation. Nat Rev Genet 5: 522–531.
19. Lim LP (2005) Microarray analysis shows that some microRNAs downregulate
large numbers of target mRNAs. Nature 433: 769–773.
20. Bushati N, Cohen SM (2008) MicroRNAs in neurodegeneration. Curr Opin
Neurobiol 18: 292–296.
21. Barringhaus KG, Zamore PD (2009) MicroRNAs: regulating a change of heart.
Circulation 119: 2217–2224.
22. Medina PP, Slack FJ (2008) microRNAs and cancer: an overview. Cell Cycle 7:
2485–2492.
23. Sethupathy P, Corda B, Hatzigeorgiou AG (2006) TarBase: A comprehensive
database of experimentally supported animal microRNA targets. Rna 12:
192–197.
24. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG
(2009) The database of experimentally supported targets: a functional update of
TarBase. Nucleic Acids Res 37: D155–158.
25. Enright AJ, John B, Gaul U, Tuschl T, Sander C, et al. (2003) MicroRNA
targets in Drosophila. Genome Biol 5: R1.
26. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ (2008) miRBase: tools for
microRNA genomics. Nucleic Acids Res 36: D154–158.
27. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by
adenosines, indicates that thousands of human genes are microRNA targets. Cell
120: 15–20.
28. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007)
MicroRNA targeting specificity in mammals: determinants beyond seed pairing.
Mol Cell 27: 91–105.
29. Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian
mRNAs are conserved targets of microRNAs. Genome Res 19: 92–105.
30. Krek A, Grun D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial
microRNA target predictions. Nat Genet 37: 495–500.
31. Bentwich I (2005) Prediction and validation of microRNAs and their targets.
FEBS Lett 579: 5904–5910.
32. Sethupathy P, Megraw M, Hatzigeorgiou AG (2006) A guide through present
computational approaches for the identification of mammalian microRNA
targets. Nat Methods 3: 881–886.
33. Zhang W, Duan S, Bleibel WK, Wisel SA, Huang RS, et al. (2009) Identification
of common genetic variants that account for transcript isoform variation
between human populations. Hum Genet 125: 81–93.
34. Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, et al. (2010) Trait-
associated SNPs are more likely to be eQTLs: annotation to enhance discovery
from GWAS. PLoS Genet 6: e1000888.
35. Gamazon ER, Zhang W, Konkashbaev A, Duan S, Kistner EO, et al. (2009)
SCAN: SNP and copy number annotation. Bioinformatics 26: 259–262.
36. Klein TE, Chang JT, Cho MK, Easton KL, Fergerson R, et al. (2001)
Integrating genotype and phenotype information: an overview of the
PharmGKB project. Pharmacogenetics Research Network and Knowledge
Base. Pharmacogenomics J 1: 167–170.
37. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, et al. (2007) A
comparison of background correction methods for two-colour microarrays.
Bioinformatics 23: 2700–2707.
38. R Development Core Team (2005) R: A language and environment for
statistical computing. Vienna, Austria: R Foundation for Statistical Computing.
39. Sing T, Sander O, Beerenwinkel N, Lengauer T (2005) ROCR: visualizing
classifier performance in R. Bioinformatics 21: 3940–3941.
40. Hanley JA, McNeil BJ (1982) The meaning and use of the area under a receiver
operating characteristic (ROC) curve. Radiology 143: 29–36.
41. Hanley JA, McNeil BJ (1983) A method of comparing the areas under receiver
operating characteristic curves derived from the same cases. Radiology 148:
839–843.
MicroRNA Gene Targets
PLoS ONE | www.plosone.org 8 October 2010 | Volume 5 | Issue 10 | e13534